Boehringer Ingelheim Pharma GmbH & Co. KG
About Boehringer Ingelheim
At Boehringer Ingelheim we create value through innovation with one clear goal: to improve the lives of patients. We develop breakthrough therapies and innovative healthcare solutions in areas of unmet medical need for both humans and animals. As a family owned company, we focus on long-term performance. We are powered by 52.000 employees globally who nurture a diverse, collaborative and inclusive culture. Learning and development for all employees is key, because your growth is our growth.
Advertisement
Product portfolio of Boehringer Ingelheim
News about Boehringer Ingelheim
Here you will find Boehringer Ingelheim Pharma GmbH & Co. KG
Last viewed contents
Herz- und Diabeteszentrum Nordrhein-Westfalen (Universitätsklinik der Ruhr-Universität Bochum) - Bad Oeynhausen, Germany
Lead Discovery Center GmbH - Dortmund, Germany
Living heart muscle slices drive RNA research into heart failure - Researchers place living human heart tissue in a nutrient solution and use it to test new drugs and innovative approaches to combat heart failure
Empa - St. Gallen, Switzerland
What Do Spiders Have in Common with Batteries? - Spider silk inspires new class of functional synthetic polymers: Conducting protein-based material could be used in fuel cells, batteries or act as sensor
Sensors against superbugs - Dangerous increase in antimicrobial resistance: Detect resistant pathogens faster and start customized treatment in good time
Circular economy for plastics - Biotechnological solutions for degradation and recycling of plastics
Artificial intelligence is drastically changing the healthcare sector - Companies are engaging with AI and investing in it, but only 29 percent feel well prepared to use GenAI for competitive advantage
Malaria Parasites Move on Right-Handed Helices - Motion patterns help the transition between tissue compartments
Coriolis Pharma Research GmbH - Martinsried, Germany